Acomplia is a winner Winner, Sanofi-Aventis Said
Sanofi-Aventis,one of the biggest company in the drug’s field, said on April 3rd it still has high hopes for Acomplia, even though it was rejected by a U.S. FDA advisory panel last year because of uncertainty of psychiatric effects.
Marc Cluzel, …